Did you miss the American Heart Association 2012 Scientific Sessions this past fall? Well Clinical Geriatrics was there and we can catch you up on anything you may have missed with this month’s First Report. Sponsored by Boehringer Ingelheim, an observational study found that dabigatran etexilate was effective and well tolerated following knee and/or hip replacement surgery. For full results regarding this study, click here. Serelaxin was also presented this year. John Teerlink, MD, presented the findings of his study on the effects of serelaxin in patients with acute heart failure. For the full article, click here.
The American Society of Consultant Pharmacists Fall 2012 Annual Meeting and Exhibition is also spotlighted in this month’s First Report.